STOCK TITAN
  1. Home
  2. IPATF

IPATF Stock Price, News & Analysis

IPATF OTC

Company Description

IPATF (OTC: IPATF) is a publicly traded biotechnology company in the Health Technology sector.

This page provides a comprehensive overview of IPATF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
0.0
Shares outstanding

Latest News

View All
—

IPA Delivers Lead Candidate Antibodies from B Cell Select™ Platform for at Home SARS-CoV-2 Diagnostic Test

—

ImmunoPrecise Reports Revenue of $3.8 Million and Adjusted EBITDA of $932,000 for the First Quarter of Fiscal 2021

earnings
—

IPA CEO Dr. Jennifer Bath to Appear Live Today on Bloomberg Television

—

ImmunoPrecise and LiteVax SARS-CoV-2 Vaccine Begins Pre-Clinical Trials

clinical trial
—

IPA Europe Significantly Expands its Capabilities, Releasing its Second-Generation B Cell Select ™

—

ImmunoPrecise Announces New Multi-Specific SARS-CoV-2 Antibody Collaboration with Zymeworks

IPATF has 10 recent news articles. Key topics include earnings, clinical trial, conferences. View all IPATF news →

SEC Filings

View All

No SEC filings available for IPATF.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

IPATF Company Profile & Sector Positioning

IPATF (IPATF) operates in the Biotechnology industry within the broader Health Technology sector and is listed on the OTC.